8-KLeadership ChangesRegulation FDExhibits & Filings

AMEREN CORP 8-K Report, Executive Changes (Oct 14, 2011)

Filed October 14, 2011For Securities:AEE

Summary

Ameren Corporation's Form 8-K filing on October 14, 2011, primarily announces a change in its Board of Directors. Catherine S. Brune was elected to fill a vacancy on the Board, with her term set to expire at the 2012 Annual Meeting of Shareholders. Ms. Brune brings significant experience from her leadership roles at Allstate Insurance Company, including her current position as President of the Allstate Protection Eastern Territory and previous role as Senior Vice President and Chief Information Officer. Furthermore, Ms. Brune has been appointed to two key committees of the Board: the Audit and Risk Committee and the Nuclear Oversight and Environmental Committee, effective December 8, 2011. Her director compensation will be in line with previously established company policies. The company has also confirmed no reportable business relationships exist between Ameren and Allstate, mitigating potential conflicts of interest.

Key Highlights

  • 1Election of Catherine S. Brune to Ameren's Board of Directors.
  • 2Ms. Brune's term as director will expire at the 2012 Annual Meeting of Shareholders.
  • 3Ms. Brune brings extensive experience from her executive roles at Allstate Insurance Company.
  • 4Ms. Brune appointed to the Audit and Risk Committee, effective December 8, 2011.
  • 5Ms. Brune appointed to the Nuclear Oversight and Environmental Committee, effective December 8, 2011.
  • 6Director compensation for Ms. Brune will follow established company arrangements.
  • 7Confirmation of no material business relationships between Ameren and Allstate.

Frequently Asked Questions

Catherine S. Brune is a senior executive from Allstate Insurance Company, currently serving as President, Allstate Protection Eastern Territory. She was elected to Ameren's Board of Directors to fill a vacancy, bringing her extensive leadership and information technology experience to the company.

Ms. Brune has been appointed to Ameren's Audit and Risk Committee and the Nuclear Oversight and Environmental Committee. These appointments will be effective starting December 8, 2011.

Ameren has stated that, to its knowledge, there are no business relationships between Allstate and Ameren or its subsidiaries that are required to be reported under SEC regulations, indicating no significant conflicts of interest at this time.

Ms. Brune will receive standard director's compensation, as previously established by Ameren and discussed in prior filings (specifically referenced as Exhibit 10.1 to Ameren's Form 10-Q for the quarter ended September 30, 2008).